Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orally Administered Misoprostol Solution (Cytotec®) Versus Orally Administered Misoprostol as a Tablet (Angusta®) for Induction of Labor in Women With Mixed Parity and an Unfavorable Cervix, a Randomized Controlled Trial.

NCT05424445 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05424445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05424445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orally Administered Misoprostol Solution (Cytotec®) Versus Orally Administered Misoprostol as a Tablet (Angusta®) for Induction of Labor in Women With Mixed Parity and an Unfavorable Cervix, a Randomized Controlled Trial.
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Completed
Start date
January 21, 2022
Completion date
May 21, 2023
Enrollment
884 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induced vaginal delivery